These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16684900)

  • 21. Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors.
    Mannangatti P; Ragu Varman D; Ramamoorthy S; Jayanthi LD
    Pharmacology; 2021; 106(11-12):597-605. PubMed ID: 34515205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function.
    Erreger K; Grewer C; Javitch JA; Galli A
    J Neurosci; 2008 Jan; 28(4):976-89. PubMed ID: 18216205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.
    Khoshbouei H; Sen N; Guptaroy B; Johnson L'; Lund D; Gnegy ME; Galli A; Javitch JA
    PLoS Biol; 2004 Mar; 2(3):E78. PubMed ID: 15024426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphetamine-induced reverse transport of dopamine does not require cytosolic Ca
    Støier JF; Konomi-Pilkati A; Apuschkin M; Herborg F; Gether U
    J Biol Chem; 2023 Aug; 299(8):105063. PubMed ID: 37468107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.
    Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG
    Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amphetamine Induces Sex-Dependent Loss of the Striatal Dopamine Transporter in Sensitized Mice.
    Bagalkot T; Sorkin A
    eNeuro; 2024 Jan; 11(1):. PubMed ID: 38164591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.
    Fraser R; Chen Y; Guptaroy B; Luderman KD; Stokes SL; Beg A; DeFelice LJ; Gnegy ME
    Mol Pharmacol; 2014 Jul; 86(1):76-85. PubMed ID: 24753048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural analysis of dopamine- and amphetamine-induced depolarization currents in the human dopamine transporter.
    Tang QY; Kolanos R; De Felice LJ; Glennon RA
    ACS Chem Neurosci; 2015 Apr; 6(4):551-8. PubMed ID: 25594379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric Modulator KM822 Attenuates Behavioral Actions of Amphetamine in
    Refai O; Aggarwal S; Cheng MH; Gichi Z; Salvino JM; Bahar I; Blakely RD; Mortensen OV
    Mol Pharmacol; 2022 Mar; 101(3):123-131. PubMed ID: 34906999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport.
    Quizon PM; Sun WL; Yuan Y; Midde NM; Zhan CG; Zhu J
    Sci Rep; 2016 Dec; 6():39048. PubMed ID: 27966610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A network of phosphatidylinositol (4,5)-bisphosphate (PIP
    Belovich AN; Aguilar JI; Mabry SJ; Cheng MH; Zanella D; Hamilton PJ; Stanislowski DJ; Shekar A; Foster JD; Bahar I; Matthies HJG; Galli A
    Mol Psychiatry; 2021 Aug; 26(8):4417-4430. PubMed ID: 31796894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine.
    Budygin EA; Brodie MS; Sotnikova TD; Mateo Y; John CE; Cyr M; Gainetdinov RR; Jones SR
    Proc Natl Acad Sci U S A; 2004 May; 101(20):7781-6. PubMed ID: 15136721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila.
    Pizzo AB; Karam CS; Zhang Y; Yano H; Freyberg RJ; Karam DS; Freyberg Z; Yamamoto A; McCabe BD; Javitch JA
    Mol Psychiatry; 2013 Jul; 18(7):824-33. PubMed ID: 22710269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphetamine exposure during embryogenesis changes expression and function of the dopamine transporter in Caenorhabditis elegans offspring.
    Ambigapathy G; McCowan TJ; Carvelli L
    J Neurochem; 2024 Sep; 168(9):2989-2998. PubMed ID: 38960397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of amphetamine actions in Caenorhabditis elegans.
    Carvelli L; Matthies DS; Galli A
    Mol Pharmacol; 2010 Jul; 78(1):151-6. PubMed ID: 20410438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization.
    Runegaard AH; Dencker D; Wörtwein G; Gether U
    Neuropharmacology; 2019 Dec; 161():107663. PubMed ID: 31173760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PI3K signaling supports amphetamine-induced dopamine efflux.
    Lute BJ; Khoshbouei H; Saunders C; Sen N; Lin RZ; Javitch JA; Galli A
    Biochem Biophys Res Commun; 2008 Aug; 372(4):656-61. PubMed ID: 18510945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anomalous dopamine release associated with a human dopamine transporter coding variant.
    Mazei-Robison MS; Bowton E; Holy M; Schmudermaier M; Freissmuth M; Sitte HH; Galli A; Blakely RD
    J Neurosci; 2008 Jul; 28(28):7040-6. PubMed ID: 18614672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation.
    Guptaroy B; Zhang M; Bowton E; Binda F; Shi L; Weinstein H; Galli A; Javitch JA; Neubig RR; Gnegy ME
    Mol Pharmacol; 2009 Mar; 75(3):514-24. PubMed ID: 19098122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.